Absolute lymphocyte count as a biomarker for best supportive care transition in metastatic breast cancer.
Saved in:
| Title: | Absolute lymphocyte count as a biomarker for best supportive care transition in metastatic breast cancer. |
|---|---|
| Authors: | Horimoto Y; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan horimoto.yoshiya.4m@tokyo-med.ac.jp.; Breast Surgery and Oncology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan., Jimbo H; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan., Ishizuka Y; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan., Nogami N; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.; Palliative Medicine, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan., Kutomi G; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan., Watanabe J; Breast Oncology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan. |
| Source: | BMJ supportive & palliative care [BMJ Support Palliat Care] 2025 Dec 23; Vol. 16 (1), pp. 231-234. Date of Electronic Publication: 2025 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101565123 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-4368 (Electronic) Linking ISSN: 2045435X NLM ISO Abbreviation: BMJ Support Palliat Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
